Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD44 as a marker in human cancers

M S Sy1, H Mori, D Liu

  • 1Institute of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44120, USA.

Current Opinion in Oncology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of PCR to the identification of dermatophyte fungi.

Journal of medical microbiology·2000
Same author

WebCat: the library catalogue on the world wide web.

Annals of the Royal College of Surgeons of England·2000
Same author

Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.

Cancer research·2000
Same author

Importance of phenylalanine 107 in agonist recognition by the 5-hydroxytryptamine(3A) receptor.

Molecular pharmacology·2000
Same author

Practical application of ergonomic settings of typical computerised workstations.

International journal of occupational safety and ergonomics : JOSE·2000
Same author

Structural basis of DOTMA for its high intravenous transfection activity in mouse.

Gene therapy·2000

CD44, a cell surface molecule, plays a key role in tumor metastasis. While CD44 isoform expression shows promise as a cancer marker, its complex regulation requires further study for diagnostic and prognostic applications.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Tumor metastasis is a critical factor in cancer patient mortality.
  • The cell surface molecule CD44 is implicated in tumor metastasis.
  • Initial findings suggested CD44 isoform expression as a potential cancer biomarker.

Purpose of the Study:

  • To review recent findings on CD44's role in cancer metastasis.
  • To explore the potential of CD44 as a diagnostic and prognostic marker for cancer patients.

Main Methods:

  • Review of recent scientific literature on CD44 and cancer metastasis.
  • Analysis of studies investigating CD44 isoform expression regulation.
  • Evaluation of CD44's diagnostic and prognostic utility.

Related Experiment Videos

Main Results:

  • CD44's involvement in tumor metastasis is complex and not fully understood.
  • Regulation of CD44 isoform expression can occur quantitatively and qualitatively.
  • Downregulation of CD44 is significant in the metastasis of certain tumor types.

Conclusions:

  • CD44's complex expression patterns present challenges for its use as a straightforward biomarker.
  • Further research is needed to elucidate CD44 regulation for effective clinical application.
  • CD44 remains a molecule of interest for potential diagnostic and prognostic advancements in cancer care.